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Complete sets of cloned protein-encoding open reading frames (ORFs), or ORFeomes, are essential tools for large-scale proteomics and
systems biology studies. Here we describe human ORFeome version 3.1 (hORFeome v3.1), currently the largest publicly available resource of
full-length human ORFs (available at www.openbiosystems.com). Generated by Gateway recombinational cloning, this collection contains 12,212
ORFs, representing 10,214 human genes, and corresponds to a 51% expansion of the original hORFeome v1.1. An online human ORFeome
database, hORFDB, was built and serves as the central repository for all cloned human ORFs (http://horfdb.dfci.harvard.edu). This expansion of
the original ORFeome resource greatly increases the potential experimental search space for large-scale proteomics studies, which will lead to the
generation of more comprehensive datasets.
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cloningWith the availability of complete genome sequences for
many organisms [1–7], it is now possible to begin systemat-
ically to identify all functional genomic elements. Of particular
interest are the elements of the genes that encode proteins,
called open reading frames (ORFs). Full-length cDNA collec-
tions, which contain 5′ and/or 3′ UTRs in addition to the ORF,
have been generated for several organisms, including Arabi-
dopsis thaliana [8], Drosophila melanogaster [9], and Homo
sapiens [10,11]. While these collections are of immense value,⁎ Corresponding authors. Fax: +1 617 632 5739.
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doi:10.1016/j.ygeno.2006.11.012they do not serve directly as ORF resources, but rather as
collections of potential ORFs that must first be subcloned
without UTRs before subsequent analysis of the encoded
proteins can be performed [12]. One such example is the
Mammalian Gene Collection (MGC) [10,13]. This extensive
collection of cDNAs was cloned into a vector that is not
immediately useful for downstream functional experimentation.
Ideally, clones should be archived in a convenient vector that
would allow for high-throughput transfer of ORFs into a variety
of different expression vectors, such as Gateway [12,14] or any
other recombinational cloning system [15–17].
In an effort to generate usable ORF collections, large-scale
cloning projects, with the goal of cloning all predicted ORFs
into flexible, recombinational vectors, have been described for a
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Saccharomyces cerevisiae [19], and Caenorhabditis elegans
[20–22]. These ORFeome resources [12] represent essential
tools for large-scale protein characterization and therefore
serve as a necessary bridge between genome annotation and
systems biology.
Previously, we have described human ORFeome v1.1 [23],
in which we used cDNAs from the MGC as templates to clone
more than 8000 full-length ORFs. The utility of the resource
was exemplified by its use in the generation of a large-scale
human protein–protein interaction or “interactome” map, in
which 6.4×107 (8000×(8000+1)) possible pair-wise combina-
tions were tested for yeast two-hybrid (Y2H) interactions,
resulting in the identification of 2754 Y2H interactions between
the products of 1549 ORFs [24]. Since linear increases in the
number of ORFs in the ORFeome collection result in quadratic
expansions in the biological search space that can be tested, the
expansion of the human ORFeome will play an essential role in
enhancing this interactome mapping effort as well as other
systematic ORF studies. For example, using a matrix-based
Y2H approach (testing all pair-wise combinations), an increase
of 4000 ORFs (from 8000 to 12,000) would allow for the testing
of 14.4×107 combinations, corresponding to an additional
8×107 pair-wise combinations and a 125% increase in the
search space. Likewise, a more complete ORFeome resource
will yield more comprehensive datasets for all systematic
studies of ORF function from protein arrays [25] to high-
content screening [26].
One of the main strategies of systems biology, the integration
of genome-wide data generated by multiple orthogonal
proteomic techniques [27], has been hampered by incompleteFig. 1. Automated human ORFeome pipeline. (A) A filter computationally removed O
nucleotides); and redundantly cloned ORFs. Isoforms and SNP variants of each gene
Gateway cloned, and sequenced at the 5′ end using universal primers. (C) The resultin
all attempted ORF sequences. Clone attempts that produced a PCR band but whose
cloning. Successfully cloned ORFs from hORFeome v1 and v3 were combined to f
isolated colonies for 564 ORFs and sequenced them at their 5′ and 3′ ends. In the
sequences will undergo full-length sequencing to generate a resource of wild-type cdatasets. As the complete human ORFeome becomes one of the
standard sets of clones used in reverse proteomic studies, the
number of analyzed proteins in large-scale experiments should
gradually improve, facilitating the integration of these data and
ultimately leading to a better understanding of the properties of
biological systems.
Here, we describe human ORFeome version 3.1 (hORFeome
v3.1), a resource of 12,212 distinct ORFs, and introduce an
improved human ORFeome database.
Results
Defining hORFeome v3.1
We define an ORF as the protein coding sequence of a gene
from its start to its stop codon and excluding the 5′ and 3′UTRs.
A major milestone of the human ORFeome project will be the
generation of the complete ORFeome, defined as the collection
of protein-encoding ORFs representing at least one splicing
isoform for every gene predicted in the human genome.
Subsequently this resource will include splice variants and
polymorphic variants for each gene.
In the first human ORFeome project (hORFeome v1.1) we
used directed PCR on the available set of cDNAs from MGC
successfully to clone 8107 ORFs into the Gateway entry vector.
In our second iteration of the human ORFeome effort, referred
to here as the human ORFeome 3 project, we have attempted to
clone ORFs from an additional 6027 cDNAs that are not part of
v1.1. These cDNAs can be divided into two classes: 4806
clones correspond to newly available MGC clones mostly
obtained by random cDNA library screening. The second classRFs, extracted from MGC cDNAs, that were not full-length; short ORFs (<100
were retained and treated as individual clones. (B) Clones were PCR amplified,
g ORF sequence tags (OSTs) were aligned to the ORFeome database containing
5′ OST did not correspond to the expected cDNA underwent a second round of
orm hORFeome v3.1. (D) To investigate the quality of this resource, we picked
upcoming ORFeome version 4 project, clones without mutations in their end
lones for each ORF in the hORFeome v3.1.
Table 2
Summary of successfully cloned ORFs compared to RefSeq annotations on each
chromosome
Chromosome No. of RefSeqs No. of ORFs Percentage of success
1 2396 1207 50.3
2 1499 775 51.7
3 1294 676 52.2
4 838 416 49.6
5 1030 514 49.9
6 1227 620 50.5
7 1077 565 52.4
8 780 397 50.8
9 904 439 48.5
10 942 435 46.2
11 1474 675 45.8
12 1219 604 49.5
13 367 189 51.5
14 748 395 52.8
15 695 346 49.8
16 972 511 52.6
17 1342 667 49.7
18 321 156 48.6
19 1539 773 50.2
20 762 321 42.1
21 372 116 31.2
22 62 30 48.3
X 573 303 52.9
Y 963 408 42.4
All 23,396 11,538 49.3
309P. Lamesch et al. / Genomics 89 (2007) 307–315of cDNAs corresponds to 1221 MGC clones that failed to clone
during the first human ORFeome project. All ORFs were passed
through a semiautomated pipeline (Fig. 1) that allowed for
efficient cloning and data analysis. First, clones shorter than 100
nucleotides (a threshold three times smaller than the convention
of 300 nucleotides), and clones for which no complete coding
sequence was available from NCBI, were eliminated from
further analysis. Isoforms or polymorphic clones of the same
gene were processed individually and treated as separate ORFs.
ORFs that we failed to clone in the first round were attempted a
second time and if successfully cloned were consolidated with
the ORFs successfully cloned in hORFeome v1.1. This
consolidated ORFeome collection is called human ORFeome
version 3.1 (Fig. 1). Even-numbered version names have been
reserved for ORFeome collections that contain single isolated
wild-type clones for each ORF [21].
ORF sequence tag (OST) analysis
Following BP recombinational cloning and transformation,
ORFs were sequenced from the 5′ end to confirm their identity.
Sequencing reads were truncated after the first 400 nucleotides
(or fewer if the sequence read was short or of low quality before
the 400th nucleotide) and used as queries for BLAST alignment
[22] against an internal database containing sequences for all of
the ORFs we attempted to clone. ORFs whose 5′OSTaligned to
the predicted sequence and contained the predicted start codon
were scored as successfully cloned.
Following two rounds of cloning, we successfully isolated
4111 ORFs. Of these, 659 corresponded to ORFs that we failed
to clone in the first version of the human ORFeome project [23],
representing a 54% recovery (659/1220). Since the primers used
here were identical to those used in our first attempt [23], the
initial cloning failures were likely due to technical errors. As
previously observed, the success rate correlated with the size of
the ORFs, with small ORFs showing a higher success rate than
larger ORFs (see Supplementary Fig. 1) [22].
In total, hORFeome v3.1 contains 12,212 ORFs, correspond-
ing to 10,214 genes, representing a 51% expansion of the ori-
ginal human ORFeome resource. The ORFs range in size from
102 to 5499 bp and include 650 polymorphic ORFs and 1160
ORFs that correspond to multiple splice forms.
Quality assessment of hORFeome v3.1
hORFeome v3.1 is a collection of clones that were generated
by PCR from unique, individual cDNA templates. Among the
PCR products from individual templates are clones withTable 1
Summary of the analysis of the nucleotide substitution rate in ORF and primer sequ
No. of analyzed
nucleotides
No. of
mutations
1 mutation every x
nucleotides
ORF
sequences
4×106 316 12,875
Primer
sequences
17×104 588 293mutations that originate during primer synthesis and clones
that acquired mutations during PCR amplification. Following
recombination, clones can also contain empty Gateway donor
vector in which the toxic ccdB gene, which normally prevents
growth of the empty vector, is no longer functional due to
mutation [12,14]. Since our cloning strategy generates mini-
pools rather than individual isolated clones for each ORF, we
did extensive sequence analysis on a set of individual isolated
clones to assess the overall quality of hORFeome v3.1.
A thorough investigation of the quality of hORFeome v3.1
was carried out by isolating single colonies from a large number
of minipools and end-sequencing them from the 5′ and 3′ ends.
Five hundred sixty-four ORFs (six plates) were chosen at
random from hORFeome v3.1 (three plates previously gener-
ated during the human ORFeome project 1 and three plates of
newly cloned ORFs) and six single isolated colonies were
picked from each well. These 3384 clones (6 plates×94
wells×6 colonies) were end-sequenced using two different
pairs of sequencing primers, corresponding to two forward and
two reverse oligonucleotides that anneal to distinct vector
sequences. In total 13,536 sequence reads were generated (3384ences in human ORFeome v3.1
No. of analyzed
sequences
No. of mutated
sequences
Percentage of mutated
sequences
9400 275 2.0
9118 557 6.1
310 P. Lamesch et al. / Genomics 89 (2007) 307–315clones×2 pairs of primers×2 reads) and only high-quality
sequence reads (at least 100 nucleotides with a PHRED score of
>19) were retained for further analysis. We expected to see
mutations that arise from two sources: mutations in the primer
sequence likely originated during primer synthesis, while those
that were found in the ORF were most likely due to PCR-
induced errors. If this were the case we should find different
rates of mutation depending on the source of mutation.
We identified mutations in 9.8% of the primers from
ORFeome project 1 and in 2.6% of the primers from ORFeome
project 3. This difference in primer quality is most likely due to a
less error-prone primer synthesis protocol used for ORFeome
project 3. The analysis of 4,068,518 nt of ORF sequence
(excluding primer sequence) revealed 316 mutations that were
distributed among 275 sequences (Table 1). The resulting
misincorporation rate using KOD polymerase (Novagen) [28]
amounts to one nucleotide substitution every 12,875 bp. This
mutation rate is higher than previously reported in hORFeome
v1.1 (one mutation every ∼35,000 bp) using the same
polymerase, but that analysis was limited to only 70,000 nt
[23]. Nevertheless, this rate is substantially lower than the
mutation rate observed in the C. elegansORFeome (1/1500 bp),
which was generated using a high-fidelity TaqDNA polymerase
[21]. Considering the much larger dataset analyzed here (4×106
in v3.1 vs 7×104 in v1.1), this study provides the most extensive
quality assessment of any large-scale ORFeome cloning project
to date.Fig. 2. Distribution of cloned ORFs within each chromosome. (A) To determine w
ORFeome, we divided each chromosome into 1-Mb bins and counted the number
represents the length (Mb) of chromosome I and the y axis the number of RefSeq sequ
bin that were cloned in the ORFeome, as indicated by the color key. If the cloning su
bar should be colored the same. Gray lines correspond to bins without RefSeq models
to the centromere (Supplementary Fig. 2 shows graphs of the remaining chromosom
function of the number of predictions in the same respective bins, NRefSeq. Three chro
straight line represents the linear regression to the data points. While only three of the
NRefSeq+ (0.42±0.32) if all chromosomes are taken into account, predicting an overhORFeome v3.1 properties
Distribution of ORFs on chromosomes
MostMGC cloneswere generated by screening a diverse set of
cDNA libraries for full-length cDNAs [29,30]. The probability of
finding a particular clone is dependent on its representation in the
library; therefore, it may be difficult to identify cDNAs that are
expressed under restricted conditions or in small subsets of cells.
Given this expression bias, are our cloned ORFs distributed
equally throughout the genome, or are there regions that are
relatively under- or overrepresented with respect to clonedORFs?
For example, inC. elegans, there is a marked underrepresentation
of cloned ORFs on chromosome 5, in a region containing a large
cluster of G-protein-coupled receptors [21].
We used BLAT to align the cloned ORFs to the human
genome using UCSC's human genome build Golden Path hg35
[31,32]. The number of ORFs associated with each chromosome
was then compared to the number of RefSeq models [33],
defined as the most comprehensive nonredundant set of full-
length cDNAs. On 22 chromosomes ORF cloning was
uniformly successful, with a cloning success rate ranging
between ∼42 and ∼53%. In contrast, cloned ORFs on
chromosome 21 were slightly underrepresented (Table 2).
To investigate ORF distribution along each chromosome, we
divided each chromosome into 1-Mb bins and counted the
number of ORFs in each bin. We calculated the cloning success
rate in each bin as the ratio of the number of cloned ORFs tohether chromosomes contain regions that are under- or overrepresented in the
of cloned ORFs and the number of RefSeq sequences in each bin. The x axis
ences in each bin. The colors of the bars reflect the percentage of RefSeqs in each
ccess rate was uniformly independent of the position on the chromosome, every
and the wide gray vertical region in the middle of the chromosome corresponds
es). (B) The number of cloned ORFs in bins 1 Mb in length, NORF, shown as a
mosomes were taken as examples in this graph (chromosomes 1, 2, and 3). The
chromosomes have been shown for clarity, the fitting yields NORF=(0.49±0.006)
all cloning success rate of about 49% for every chromosomal bin.
311P. Lamesch et al. / Genomics 89 (2007) 307–315RefSeq sequences (Fig. 2A). To check quantitatively whether
there is a bias toward sparse or dense RefSeq regions in the
cloning success rate, we plotted the number of cloned ORFs
versus the number of RefSeq models for each bin for three
chosen chromosomes (Fig. 2B). We find that the ORF density isFig. 3. Classification of cloned ORFs by GO Slim terms. To identify over- or underre
by GO Slim terms within their three GO branches, (A) cellular component, (B) molec
Slim term found in the ORFeome to that of the entire proteome. No GO Slim termlinearly proportional to the RefSeq density and that the overall
cloning success rate is ∼49% for every bin of chromosomes,
showing that the cloned ORFs are equally distributed within
chromosomes and that there are no regions of obvious over- or
underrepresentation. We then compared the distribution of thepresented functional categories of proteins in the ORFeome, we classified ORFs
ular function, and (C) biological process, and compared the fraction of each GO
in any of the three branches is over- or underrepresented in the ORFeome.
312 P. Lamesch et al. / Genomics 89 (2007) 307–315local success rates among chromosomes and noticed a
significantly different local success rate distribution on chromo-
somes 19, 20, 21, X, and Y (Supplementary Fig. 3). On
chromosomes 20, 21, and X, this shift could be explained by the
lower overall cloning success rate. On chromosomes 19 and Y,
for which the cloning success rate was high, this shift might be
due to erroneous gene annotation or related to the fact that these
two chromosomes are among the shortest of chromosomes.
GO Slim terms
We turned to Gene Ontology (GO) annotations [34,35] to
assess whether specific functional categories were over- or
underrepresented in human ORFeome version 3.1. Instead of
the full GO hierarchy, we used the broader GO Slim terms of
each GO branch (cellular component, biological process, and
molecular function). We compared the fraction of each GO term
found in clones in the ORFeome to the fraction found in the
entire proteome (Fig. 3). We find that the ORFeome has a very
similar profile of functional categories compared to the
complete human proteome, with no obvious over- or under-
enriched categories.
Disease genes
Disease-associated genes are obviously of great interest to the
research community. The OMIM (OnlineMendelian Inheritance
in Man) database [35] represents the central repository for
information about inherited disease-related genes. OMIM
currently contains information for about 2801 genes that areFig. 4. Representation of disease genes in hORFeome v3.1. The list of inherited dise
diseases were grouped into 22 disease categories based on the physiological system
disease category for which we cloned at least one associated ORF.associated with 1585 different diseases. hORFeome v3.1
contains 956 disease genes associated with 828 distinct diseases
described in OMIM (Fig. 4). We classified all OMIM diseases
into 22 categories (containing between 6 and 239 different
diseases) based on the physiological system affected. We then
determined how many diseases in each disease category were
represented by at least one ORF in hORFeome v3.1. We could
identify ORFs associated with 40–60% of the diseases within a
given category, except a few slightly over- (cancer, hematolog-
ical diseases) or underrepresented (ear–nose–throat-related
diseases) categories. For example, v3.1 contains ORFs for 86
of 132 diseases that belong to the cancer category. Despite the
good representation of OMIM genes in the ORFeome, only
9.7% of all cloned ORFs have been associated with an inherited
disease. The generation of large ORF collections, such as
hORFeome v3.1, will be crucial for the identification and
characterization of additional disease associations.
hORFDB 3.1 Web site
A new Web site (http://horfdb.dfci.harvard.edu) that
improves both the user interface and the back end has been
developed. Searches on the hORFDB 3.1 Web site can be
performed for single or multiple clones using different queries,
including MGC name, GI, GenBank accession number,
EntrezGene ID, OST accession number, symbol, or plate
position. The database can also be searched by description or
keyword for ORFs involved in specific biological functions orases and their associated genes was retrieved from the OMIM database, and the
affected. The length of each bar represents the percentage of diseases in each
313P. Lamesch et al. / Genomics 89 (2007) 307–315diseases. The result page of a successfully cloned ORF provides
information about the location of the ORF in the ORFeome
resource, primer and GenBank sequences, and alternative IDs
and descriptions for the ORF.
Any yeast two-hybrid interactions based on the human
interaction dataset produced by Rual et al. [24] are also listed.
These interactions can be visualized using the network
visualization tool VisANT [36]. If the queried protein has
been detected as bait or prey in the above-mentioned interaction
dataset, hORFDB links directly to a first-level interaction
network (proteins that interact directly with the queried protein)
and a second-level interaction network (proteins that interact
with the interaction partners of the queried protein). The user
can expand the visible network by clicking on each node of
interest, thereby revealing the next level of interactors. Each
protein in the network contains links back to its corresponding
hORFeome v3.1 Web page, as well as to its corresponding
pages on the NCBI EntrezGene, NCBI Nucleotide, and KEGG
Web sites.
All ORFs labeled as cloned in hORFDB are part of the
physical resource of ORF Entry minipools and are available
from Open Biosystems, Inc. (http://www.openbiosystems.com).
The complete list of cloned human ORFs is also available as a
downloadable Fasta file on our home page.
Discussion
hORFeome v3.1 greatly expands the human ORFeome
collection. Unique MGC cDNAs, initially generated largely by
random cDNA library screening, were used individually as
templates to clone successfully 4111 additional ORFs, gener-
ating a consolidated collection of 12,212 ORFs representing
10,214 genes. Although random library screening followed by
PCR amplification and Gateway cloning is an excellent method
to clone ORFs corresponding to more than half of the well-
defined RefSeq predictions, this approach would be less
efficient for the identification of “rare” ORFs. Strategies to
overcome this hurdle are to generate normalized cDNA libraries
or to presubtract cDNAs retrieved in previous screens. An
alternative approach is to perform directed PCR from cDNA
using primers that have been designed based on ORF
predictions, as has been successful for C. elegans [21].
Recently, the MGC, Integrated Molecular Analysis of
Genomes and Their Expression Consortium, Wellcome Trust
Sanger Institute, DFCI–CCSB (Dana Farber Cancer Institute–
Center for Cancer Systems Biology), Harvard Institute of
Proteomics, Deutsches Krebsforschungszentrum, Kazusa DNA
Research Institute, and RIKEN Yokohama Institute initiated the
human “ORFeome Collaboration” with the aim of sharing
existing resources and dividing the task of completing the
human ORFeome [37]. This effort is using directed PCR to
clone missing ORFs whose exon–intron structure is annotated
based on literature or full-length cDNAs. About 4700 ORFs that
meet these criteria are currently being processed. In addition to
library screening and directed PCR, direct ORF synthesis is a
third approach to expand the human ORFeome and will be
particularly valuable for ORFs that prove difficult to clone. In asmall pilot project to demonstrate the feasibility of the synthetic
approach, the MGC recently contracted for the successful
synthesis and cloning of 72 ORF sequences, ranging in size
from several hundred nucleotides to over 11 kb (Gary Temple,
personal communication).
In addition to gene coverage, future versions of the human
ORFeome will increase coverage of alternatively spliced genes.
While recent estimates predict that up to 80% of all human
genes code for multiple isoforms, only 1160 ORFs correspond
to splice variants in hORFeome v3.1. Finally, while the current
ORFeome is a collection of minipools, each initially derived
from a single, fully sequenced cDNA template, we ultimately
want to generate a resource of wild-type clones, which will
require the isolation and full-length sequencing of single
colonies for each ORF in the minipools.
Materials and methods
Gateway cloning of the human ORFeome v3.1
For PCR amplification, we designed primers using the automatic primer
design program OSP [38]. Although this program is no longer publicly
available, we suggest using Primer3 [39] as an alternative primer design
program. Forward primers start from the A of the ATG, whereas the reverse
primers start from the second nucleotide in the stop codon. Consequently, the
reverse attb2.1 primers do not contain the last nucleotide of the termination
codon, so as to allow subsequent generation of C-terminal fusion proteins. For
ORFs that failed in the first ORFeome project and that we reattempted to clone
in ORFeome version 3, we did not synthesize new primers but instead used the
primers generated for the previous project. To generate hORFeome v3.1 we
closely followed the protocol of Reboul et al. [21], except that we applied the
improved PCR conditions and used the improved donor vector pDONR223
[23].
All nonredundant MGC clones were consolidated into a unique set (some
MGC clones exist in duplicates) and arranged by size of the ORF and by
antibiotic resistance marker. Plasmid preps were obtained using a Qiagen
Biorobot 8000. PCR was performed in 25-μl reactions containing 1 unit of KOD
Hot Start DNA polymerase according to the manufacturer (Novagen). Gateway
BP reactions were performed as described [23] using 2 μl of unpurified PCR
product in 10 μl final volume. A 2-μl aliquot of the BP reaction was used to
transform Escherichia coli DH5a to spectinomycin resistance (50 μg/ml).
Plasmid preps were obtained from 1.0-ml overnight cultures and then used for
PCR with M13-based Fwd and Rev primers to generate templates for cycle-
sequencing reactions [23]. PCR products were sequenced at the 5′ end using the
M13-Fwd primer, generating an OST.
Sequence analysis of the initial MGC cDNAs
For this ORFeome project, we attempted to clone ORFs from 9236 MGC
cDNA clones that either were not yet available or remained uncloned in
hORFeome v1.1. The coding sequences of all these cDNAs were retrieved from
the NCBI Web site and compared to one another to eliminate any cDNAs
containing redundant open reading frames (this includes duplicate clones as well
as those cDNAs with different 5′ and/or 3′ UTRs but otherwise identical ORF
sequences). Next, we aligned the set of unique coding sequences to the human
genome (Golden Path hg35) and identified ORFs that were splice variants or
polymorphic clones of the same gene.
Sequence analysis of OSTs from minipools
First, OSTs were used as queries for BLASTN searches against our internal
database containing all coding sequences that we attempted to clone. In a second
step, aligned OSTs were truncated after the first 400 nucleotides (or fewer if the
sequence read was short or of low quality before the 400th nucleotide) and a
314 P. Lamesch et al. / Genomics 89 (2007) 307–315BLAST (blast2seq) was performed between each OST sequence and its best hit.
Based on these results, OSTs were grouped into the following classes: (1) good,
(2) good but potential polymorphism detected, (3) good but not full length, (4)
wrong identity, and (5) empty clones. Only OSTs of categories (1) and (2) were
retained for further analysis.
Sequence analysis of OSTs from isolated colonies
Five hundred sixty-four ORFs (six 96-well plates) were selected from the
ORFeome 3.1 collection to represent a variety of insert sizes, including the
smallest and largest ORFs. Minipools were streaked to single colonies on LB
agar containing 100 μg/ml spectinomycin and incubated at 37 °C for 16 h. Six
colonies were selected for further analysis. Individual colonies were picked into
0.8-ml 96-well plates (ABgene AB-0859) containing 0.5 ml of selective growth
medium (Circlegrow supplemented with 100 μg/ml spectinomycin) and grown
in a shaking incubator at 37 °C for 16 h. The sequencing template was prepared
for successfully cultivated colonies by standard alkaline-lysis plasmid
purification. Initial end sequencing was performed with BigDye terminator v3
Cycle Sequencing Kits (Applied Biosystems) using M13 forward
(TGTAAAACGACGGCCAGT) and reverse (CAGGAAACAGCTATGACC)
primers and primers designed to pDONR223 (CCCAGTCACGACGTTG-
TAAAACG; GTAACATCAGAGATTTTGAGACAC) on ABI 3730 sequenc-
ing machines. Reads were analyzed for the presence of a complete att site, the
correct insert sequence, and the presence of the gene-specific oligonucleotide
using crossmatch (Green P, http://www.phrap.org/phredphrap/general.html) and
Blastn.
Analysis of successful ORF clones on chromosomes
Sequences of the RefSeq set (June 2005), NCBI's consensus set of
nonredundant transcripts, were used as queries to perform a BLAT alignment to
the human genome build hg35.1. We chose only those RefSeq models that fulfill
the following requirements: (1) RefSeqs are of the “NM” category, which
corresponds to sequences that have been validated by one or more cDNAs and
(2) they are known as “protein-coding” by NCBI. Using their genomic
coordinates, cloned ORFs and RefSeqs were grouped into 1-Mb bins on all
chromosomes. The distribution of RefSeq models and the ORF cloning success
rate on the chromosomes were plotted using Matlab 6.
In the scatter graph of Fig. 2B, we find that the ORF density is linearly
proportional to the RefSeq density, as described by the function NORF=0.49
NRefSeq+0.42 (the standard errors are 0.006 and 0.32 for the slope and the
intercept of the regression function, respectively) for the given binning and
considering every chromosome.
Analysis of ORF distribution by functional classes
Gene ontology functional classification was obtained from the EntrezGene
database at ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/gene2go (April 6, 2006).
Each gene-to-GO term association was mapped to a GO Slim association as
defined in ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/goslim/goaslim.map (Feb-
ruary 27, 2006). The frequency distribution of ORFs in each GO Slim class was
then calculated for ORFs in hORFeome v3.1 as well as for the entire proteome.
Analysis of ORF distribution by disease category
The list of human diseases and their associated genes was obtained from the
OMIM database at ftp://ftp.ncbi.nih.gov/repository/OMIM/morbidmap. Similar
diseases were collapsed into just one disease. We then manually curated these
diseases and divided them into 22 classes mostly based on the type of disease
(such as cancer) and the physiological system affected.
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